Neurobiology of the Gilles De La Tourette Syndrome and Chronic Tics: Part B

Preface
Marc E. Lavoie and Andrea E. Cavanna
1. The genetic basis of Gilles de la Tourette syndrome
Sarah B. Abdallah, Evan Realbuto, Mary Oluwatosin Kaka, Kelly Yang, Apostolia Topaloudi, Peristera Paschou, Jeremiah M. Scharf and Thomas V. Fernandez
2. Studying the pathophysiology of tic disorders in animal models
Christopher Pittenger
3. The neural-immune crosstalk in Tourette syndrome: From immunobiology to epistemology
Yasamin Mahjoub, Davide Martino and Andrea E. Cavanna
4. Functional connectivity in the Gilles de la Tourette syndrome
Matthew Feigelis and Deanna J. Greene
5. Perception-action integration in Gilles de la Tourette syndrome
Theresa Paulus, Christian Beste and Alexander Muenchau
6. The pharmacological treatment of Tourette syndrome
Jose Fidel Baizabal-Carvallo and Joseph Jankovic
7. Ecopipam: A D1 receptor antagonist for the treatment of Tourette syndrome
Richard E. Chipkin, Donald L. Gilbert and Atul Mahableshwarkar
8. Atypical antipsychotics for treatment of Tourette syndrome
Vamsi K. Kalari, Peter E. Morrison and Cathy L. Budman
9. Alpha agonists for the treatment of Tourette syndrome
Nick Cothros and Tamara Pringsheim
10. Cannabinoids: Possible role in the pathophysiology and therapy of Gilles de la Tourette syndrome
Natalia Szejko and Kirsten Mueller-Vahl
11. Novel potential avenues for the therapy of Tourette syndrome: Cannabinoid and steroid-based tools
Marco Bortolato and Roberto Cadeddu
12. Non-invasive brain stimulation for the treatment of Tourette's syndrome
Sneha Chenji, Kayla D. Stone and Frank P. MacMaster
13. Entrainment of movement-related brain oscillations to improve symptoms in Tourette syndrome
Mairi Houlgreave, Barbara Morera Maiquez, Katherine Dyke, Georgina Jackson and Stephen Jackson
14. Network oscillatory activity in chronic tics and Tourette syndrome
Joohi Jimenez-Shahed

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Dispositivos e materiais electrónicos
• Física da Matéria Condensada (física do estado sólido e estado líquido)
• Neurologia e neurofisiologia clínica
• Electrónica e engenharia das comunicações
• Ciência dos materiais
• Física

2-AG; Action file; Adolescence; Allergies; Alpha-2 adrenergic agonists; Animal models; Antagonist; Antipsychotics; Atypical antipsychotics; Basal ganglia; Beta; Brain networks; Cannabinoids; Cannabis; Cannabis based medicine; Child and adolescent psychiatry; Childhood; Clinical trial; Clonidine; Copy-number variation; Cortex; D1 receptor; Deep brain stimulation; Dopamine; Dopamine depleters; Dronabinol; Ecopipam; EEG; Endocannabinoid modulator; Endocannabinoid system; Entrainment; Epistemology; Event file; Exome sequencing; fMRI; Functional connectivity; Genetics; Genome-wide association; Genomics; Gilles de la Tourette syndrome; Globus pallidus interna; Guanfacine; Heritability; Immunity; Infections; Interneurons; Local field potentials; Median nerve stimulation; MEG; Motor; Mu-alpha; Nabiximols; Neuroactive steroids; Non-invasive brain stimulation; Object file; Oscillation; Pathway analysis; Pediatric; Pediatric neurology; Perception-action integration; Pharmacological therapy; Polygenic risk; Resting state; Second generation antipsychotics; Sensorimotor; Sensorimotor processing; Supplementary motor area; Thalamus; THC; Theory of Event Coding; Tic disorders; Tics; Topiramate; Tourette; Tourette syndrome; Tourette's syndrome; Transcranial direct current stimulation; Transcranial magnetic stimulation